yuFlu

yuFlu is the first DTC sequencing as a service screen for COVID-19 & other respiratory infections that uses FDA-cleared collection devices.

yuFlu in the News

Meet yuFlu

yuFlu is a mission-driven molecular testing company founded in 2018. We build consumer-friendly solutions for nonspecific respiratory symptoms commonly referred to as flu and "flu-like" symptoms. Our mission is to reduce disease transmission and antimicrobial abuse through consumer-focused care. yuFlu is a full-solution care platform for influenza-like illness (ILI) that offers sequencing as a service (SAS) for respiratory pathogens, including COVID-19. We leverage the throughput of next-generation sequencing technology to offer 1 test that screens for 100s of pathogens all for the cost of a co-pay.

Why is your company the best option to solve the problem you're solving?

yuFlu believes knowing why you're sick is a basic human right, and knowing why our community is sick is a public good. yuFlu has assembled the best team to sustainably solve the problem of poor, non-statistically significant pathogen surveillance data. Our solution is consumer engagement. Every time you swab with yuFlu you not only contribute to your health, but you also contribute to the health of your friends, family, and community. Unlike other at-home tests in development, yuFlu generates comprehensive pathogen sequence data capable of distinguishing between novel strains of viruses, bacteria, and fungi - including drug resistance markers - with uniquely high economies of scale. Our gold-standard data strengthens public health systems benefiting all people, nations, and generations.

What nuggets of info make you interesting? Why do people care about what you're doing?

yuFlu's commitment to the community is in our DNA (literally). We are actively involved in supporting local companies to return to the workplace through our partnership with Biocom. We are also partnered with non-profits who are committed to supporting homeless veterans with access to testing.